Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer's treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients.
By Madeline Kennedy(Reuters Health) - Many sleep apnea patients may have impaired attention and decision-making ability, even if they are being treated with continuous positive airway pressure (CPAP), a small study suggests.
By Will Boggs MDNEW YORK (Reuters Health) - Nocturnal hot flashes and sleep disturbance independently contributed to depression in women with artificially-induced estrogen deprivation, researchers report.
By Madeline Kennedy
(Reuters Health) - Health might be its own reward, but even cash incentives only work in the short term to motivate people to exercise more and activity trackers add little benefit, according to a study from Singapore.
Bowing to public pressure, the U.S. Drug Enforcement Administration (DEA) said on Thursday it had delayed a decision on whether to classify the botanical substance kratom, which is available online in the United States as a dietary supplement, as a…